- Home
- LBTYB vs LNTH Comparison
LBTYB vs LNTH Comparison
Compare LBTYB & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LBTYB | LNTH |
|---|---|---|
| Founded | 2004 | 1956 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.8B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | LBTYB | LNTH |
|---|---|---|
| Price | $10.96 | $63.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $74.17 |
| AVG Volume (30 Days) | 1.2K | ★ 1.1M |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.39 |
| Revenue | ★ $4,770,600,000.00 | $1,525,933,000.00 |
| Revenue This Year | $13.25 | $0.01 |
| Revenue Next Year | $1.75 | $1.24 |
| P/E Ratio | ★ N/A | $26.45 |
| Revenue Growth | ★ 170.50 | 1.95 |
| 52 Week Low | $9.15 | $47.25 |
| 52 Week High | $14.91 | $111.29 |
Technical Indicators
Market Signals| Indicator | LBTYB | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 47.61 | 71.16 |
| Support Level | $11.11 | $57.44 |
| Resistance Level | $11.92 | $59.30 |
| Average True Range (ATR) | 0.19 | 2.14 |
| MACD | -0.02 | 0.82 |
| Stochastic Oscillator | 28.75 | 91.35 |
Price Performance
Historical ComparisonAbout LBTYB Liberty Global Ltd. Class B
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.